Partners

Make the Most of our Expertise in Tissue Based Biomarker Analysis

HistologiX is a trusted GLP & GCP compliant CRO, specialising in advanced, tissue-based biomarker analysis across therapeutic and medical device development pipelines. Known for their scientific rigor and consultative approach, HistologiX supports both clinical and pre-clinical studies with a comprehensive suite of histology, immunohistochemistry (IHC), immunofluorescence (IF), in situ hybridization (ISH), and cutting-edge digital image analysis services.

HistologiX's proactive and flexible approach accommodates novel targets as well as those already well defined. They offer an extensive panel of chromogenic and immunofluorescence, single and multiplex IHC assays, all with outstanding reproducibility. Drawing on the expertise of their scientific team HistologiX develops, optimises and validates biomarker assays for use in distribution, proof of concept of mechanism of action studies. For each project, their experienced scientists work as an extension of your in-house team to define your bespoke project requirements and customise the study plan to ensure you get the results you need. They provide an excellent quality technical service supporting biomarker evaluation of cutting-edge therapeutics including cell and gene therapies, oncolytic viruses, therapeutic antibodies, small molecules, and RNA modifying enzymes. 

Partner with HistologiX to generate and turn tissue-based data into decisions to accelerate the development of your therapeutic or medical device.

For more information, visit www.histologix.com